Huntleys' Stock of the Week
Mesoblast Announces Agreement with Abbott for Stem Cell Heart Failure Therapy
Tuesday February 19, 2008, 10:01 am

Original Announcement: Agreement with Abbott for Stem Cell Heart Failure Therapy

Mesoblast announced that its US-based sister company, Angioblast Systems Inc., has entered into a collaborative agreement with Abbott, a major global broad-based healthcare company, for the development and commercialisation of Angioblast's catheter-based cell therapy product for heart failure. Abbott will provide funding for the collaborative program.

More information about MSB.AX
  •   

    • Copyright © 2010 Yahoo!7 Pty Limited. All rights reserved.
    Advertise with Us - Privacy Policy - Terms of Service - Help